These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18606074)

  • 1. [Fiber, cancer stem cells, and the Wnt signaling continuum: possibilities for colorectal cancer prevention and therapeutics].
    Bordonaro M; Sartorelli AC
    Ai Zheng; 2008 Jul; 27(7):766-70. PubMed ID: 18606074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer?
    Bordonaro M; Lazarova DL; Sartorelli AC
    Oncol Res; 2008; 17(1):1-9. PubMed ID: 18488710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
    Bordonaro M; Lazarova DL
    World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk?
    Bordonaro M; Lazarova DL; Sartorelli AC
    Cell Cycle; 2008 May; 7(9):1178-83. PubMed ID: 18418037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors.
    Bordonaro M; Lazarova DL; Sartorelli AC
    Exp Cell Res; 2007 May; 313(8):1652-66. PubMed ID: 17359971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
    Lazarova D; Bordonaro M
    J Cancer; 2017; 8(8):1453-1459. PubMed ID: 28638460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
    Lazarova DL; Chiaro C; Wong T; Drago E; Rainey A; O'Malley S; Bordonaro M
    J Cancer; 2013; 4(6):481-90. PubMed ID: 23901348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vimentin, colon cancer progression and resistance to butyrate and other HDACis.
    Lazarova DL; Bordonaro M
    J Cell Mol Med; 2016 Jun; 20(6):989-93. PubMed ID: 27072512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate.
    Lazarova DL; Bordonaro M; Carbone R; Sartorelli AC
    Int J Cancer; 2004 Jul; 110(4):523-31. PubMed ID: 15122584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
    Lazarova DL; Wong T; Chiaro C; Drago E; Bordonaro M
    J Cancer; 2013; 4(6):491-501. PubMed ID: 23901349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis: Sam68 and Pygo2 mediate cell type-specific effects of the modulation of CBP-Wnt and p300-Wnt activities in Colorectal Cancer Cells.
    Bordonaro M
    J Cancer; 2021; 12(16):5046-5052. PubMed ID: 34234873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.
    Lazarova D; Lee A; Wong T; Marian B; Chiaro C; Rainey C; Bordonaro M
    J Cancer; 2014; 5(3):203-13. PubMed ID: 24563675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells.
    Bordonaro M; Tewari S; Cicco CE; Atamna W; Lazarova DL
    PLoS One; 2011; 6(11):e27308. PubMed ID: 22073312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis: Retinoblastoma protein inactivation mediates effects of histone deacetylase inhibitor-induced Wnt hyperactivation in colorectal cancer cells.
    Bordonaro M
    J Cancer; 2020; 11(3):668-677. PubMed ID: 31942190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells.
    Götze S; Coersmeyer M; Müller O; Sievers S
    Int J Oncol; 2014 Oct; 45(4):1715-23. PubMed ID: 25050608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
    Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S
    Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
    Chiaro C; Lazarova DL; Bordonaro M
    Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells.
    Bordonaro M; Lazarova DL; Sartorelli AC
    Nucleic Acids Res; 2004; 32(8):2660-74. PubMed ID: 15141037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.